【大河财立方 记者 王磊彬】2月18日晚间,真实生物科技有限公司(以下简称真实生物)递表港交所主板,中金公司为其独家保荐人。这是继2022年8月4日之后,真实生物第二次申请在港交所上市。根据弗若斯特沙利文的资料,由真实生物研发生产的阿兹夫定,具有广谱抗病毒活性,是全球唯一一款用于治疗HIV的双靶点口服核苷药物,目前已经覆盖了全国31个省市区超过50000家医疗终端。时隔两年多真实生物二度赴港...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.